Carlos Rivera
Internal Medicine · Ponce, PRNPI 1518365063
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 458 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Johnson & Johnson$1K
- Amgen$1K
- E.r. Squibb & Sons, L.L.C.$805
- Merck$782
- Eli Lilly Export S.A. Puerto Rico Branch$768
- plus $5K from 33 others
What the payments were for
- Food & beverage$11,00095%
- Education$5225%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 63 | $1,432 |
| Johnson & Johnson(2 entities) | 54 | $1,250 |
| Amgen | 34 | $1,015 |
| E.r. Squibb & Sons, L.L.C. | 36 | $805 |
| Merck | 38 | $782 |
| Eli Lilly Export S.A. Puerto Rico Branch | 34 | $768 |
| AbbVie | 27 | $613 |
| PBG Puerto Rico LLC | 27 | $562 |
| Sanofi | 11 | $507 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $476 |
| Novartis | 19 | $415 |
| Pfizer | 9 | $334 |
| Genentech USA, Inc. | 12 | $261 |
| Eisai Inc. | 11 | $223 |
| Incyte Corporation | 6 | $183 |
| Rigel Pharmaceuticals, Inc. | 4 | $179 |
| Sobi, Inc | 8 | $177 |
| Verity Pharmaceuticals Inc. | 4 | $173 |
| Exelixis Inc. | 8 | $150 |
| Bayer | 3 | $145 |
| Karyopharm Therapeutics Inc. | 1 | $125 |
| Bard Peripheral Vascular, Inc. | 3 | $119 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Beigene USA, Inc. | 5 | $107 |
| Bayer Puerto Rico Inc. | 4 | $92 |
| Pharmaessentia USA Corporation | 3 | $74 |
| GSK | 3 | $65 |
| Tempus AI, Inc | 3 | $64 |
| Caris MPI, Inc. | 2 | $53 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Gilead | 2 | $43 |
| Organon | 1 | $25 |
| Beone Medicines USA, Inc. | 1 | $25 |
| Taiho Oncology, Inc. | 1 | $24 |
| Global Blood Therapeutics, Inc. | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $19 |
| Seagen Inc. | 1 | $17 |
| Immunogen, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,523 in reported general payments places this provider in the 95th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 17 | $172 |
| Prednisone | 26 | $132 |
| Ondansetron Hcl | 13 | $115 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Ponce
- Hector Martinez FornaPonce$19K
- Elizabeth BarrancoPonce$15K
- Enrique Rodriguez-PazPonce$14K
- Darcy Diago BlancoPonce$10K
- Rafael Espinet PerezPonce$7K
- Brian Torres MercadoPonce$6K
- Raul Cota LeyPonce$6K
- Humberto SimonettiPonce$6K
- Stephen Bury FiolPonce$5K
- Eduardo Colon MelendezPonce$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.